¶ lactose intolerance
¶ Definition
Lactose intolerance is the inability to digest lactose (milk sugar) due to insufficient lactase enzyme (lactase-phlorizin hydrolase, LPH) in the small intestinal brush border. This represents the ancestral human phenotype: after weaning, lactase gene expression downregulates in approximately 65% of the global adult population. Lactase persistence—continued production into adulthood—is the derived genetic variant that arose independently in dairy-farming populations within the last 10,000 years, representing one of the strongest recent positive selection signals in human evolution.
¶ Picture It
Imagine a factory assembly line designed to break down complex packages (lactose) into simple components (glucose and galactose) that workers (enterocytes) can handle. In infants, this assembly line (lactase enzyme) runs at full capacity—every baby needs it to digest breast milk. After weaning, most humans shut down this assembly line to save energy—the factory assumes milk is no longer on the menu.
But in some populations—Northern Europeans, East Africans, and a few others—a genetic "manager memo" keeps the assembly line running for life. This happened because these populations domesticated dairy animals and made milk a year-round food source. The factory adapted to the new reality.
When a lactose-intolerant person drinks milk, unprocessed packages pile up in the warehouse (small intestine). These packages can't be absorbed, so they roll into the next department (colon), where bacterial workers start tearing them apart through fermentation. This creates gas (hydrogen, methane, CO₂), acids (SCFAs), and pulls water into the colon osmotically—like a burst pipe flooding the basement. Result: bloating, cramping, gas, and diarrhea within 30 minutes to 2 hours.
The severity depends on three things: how much lactose you consume, how many assembly-line workers are left (residual lactase activity ranges from 5-50% in "intolerant" individuals), and which bacterial workers show up to the cleanup job—some produce more gas than others.
¶ Mechanism
¶ Lactase Expression and Downregulation
-
Infant lactase expression: The LCT gene (chromosome 2q21) encodes lactase-phlorizin hydrolase (LPH), a brush border enzyme anchored in the apical membrane of jejunal enterocytes. In infants, transcription factors bind to the LCT promoter region, driving high expression (50-100 U/g protein).
-
Post-weaning downregulation (ancestral pattern):
- Between ages 2-5, regulatory elements upstream of LCT (-13910 and -22018) remain unmethylated in lactose-intolerant individuals
- Oct-1 transcription factor binding decreases at the LCT promoter
- LCT mRNA transcription drops by 90-95%
- Lactase protein levels decline to 5-10% of infant levels by age 5-10
-
Lactase persistence mutation (derived):
- -13910 C>T polymorphism (rs4988235) in Europeans
- -13907 C>G and -14010 G>C in East Africans
- These SNPs create binding sites for transcription factors (e.g., Oct-1, HNF1α) that maintain LCT expression
- Heterozygotes show intermediate lactase activity (30-70% of infant levels)
- Homozygous T/T individuals maintain 70-100% activity lifelong
¶ Lactose Malabsorption Cascade
When lactase is insufficient:
Molecular details:
- SGLT1 (sodium-glucose linked transporter 1) requires monosaccharides—cannot transport disaccharide lactose
- Unabsorbed lactose creates osmotic gradient: 1 gram lactose retains ~15 mL water
- Colonic bacteria (Bacteroides, Lactobacillus, E. coli) possess β-galactosidase enzymes
- Fermentation produces:
- Hydrogen gas (measured in hydrogen breath test: >20 ppm rise from baseline = malabsorption)
- Methane gas in 30-40% of individuals (methanogen colonization)
- SCFAs (beneficial but contribute to acidification and motility)
- Acidification triggers TRPV1 and ASIC (acid-sensing ion channels) on visceral afferents
- Distension activates mechanoreceptors → signals to dorsal horn → pain perception
¶ Dose-Response and Threshold Effects
- Lactose load threshold: most intolerant individuals tolerate <12 g lactose (1 cup milk = ~12-15 g)
- Symptom severity correlates with residual lactase activity:
- <10% activity: symptoms at 5-10 g lactose
- 10-30% activity: symptoms at 12-24 g
- 30-50% activity: may tolerate 24+ g with mild symptoms
- Gastric emptying rate affects symptoms: slower emptying → less bolus delivery → better tolerance
- Colon transit time matters: faster transit = less fermentation time, fewer symptoms
¶ Clinical Significance
¶ Evolutionary Context and Population Variability
Lactose intolerance is not a disease—it is the default human phenotype. Lactase persistence is a recent evolutionary adaptation (5,000-10,000 years) representing one of the strongest positive selection signals in human genomics. Understanding this prevents pathologization of normal biology.
Global prevalence of lactose intolerance:
- Northern Europeans: 5-15% (highest lactase persistence)
- Southern Europeans: 40-50%
- East Asians: 90-100%
- Sub-Saharan Africans: 65-75% (except East African pastoralists: 10-30%)
- Native Americans: 80-100%
- Ashkenazi Jews: 60-70%
This distribution directly correlates with ancestral dairy farming history—a textbook example of gene-culture coevolution and evolutionary mismatch.
¶ Diagnostic Considerations
-
Lactose hydrogen breath test:
- Gold standard: measures Hâ‚‚ rise after 25-50 g lactose load
- Positive: >20 ppm rise from baseline within 3 hours
- False negatives: non-H₂ producers (methanogen-dominant microbiome—measure CH₄ instead)
-
Genetic testing:
- -13910 C>T genotyping: C/C = intolerant, C/T = intermediate, T/T = persistent
- More definitive than breath testing (not affected by microbiome or transit time)
- Important for distinguishing from IBS, SIBO, or Small intestinal bacterial overgrowth
-
Differential diagnosis:
- Must distinguish from A1 beta-casein intolerance (protein issue, not carbohydrate)
- SIBO can mimic lactose intolerance (bacterial overgrowth fermenting lactose in small intestine)
- Secondary lactase deficiency from gut dysbiosis, celiac disease, or inflammatory bowel disease
- IBS: lactose is a FODMAP—symptoms overlap completely
¶ Microbiome and Inflammatory Implications
Connection to dysbiosis:
- Chronic lactose malabsorption selects for gas-producing bacteria
- Shifts microbiome toward Proteobacteria, reduces Firmicutes diversity
- Contributes to SIBO risk—fermentation begins too proximally
- Can trigger leaky gut through chronic distension and acidification
- May activate NLRP3 inflammasome via bacterial metabolites
Inflammatory cascade in susceptible individuals:
- Undigested lactose → bacterial overgrowth → LPS translocation
- LPS binds TLR4 → NF-κB activation → IL-6, TNF-α, IL-1β
- Chronic low-grade inflammation mimics metaflammation
- Particularly problematic in individuals with existing gut barrier dysfunction
¶ Clinical Decision-Making
For lactase-persistent populations (Northern European ancestry):
- Dairy provides Calcium, Vitamin D (fortified), protein, butyrate (from fermented dairy)
- Fermented dairy (yogurt, kefir) contains Lactobacillus species producing β-galactosidase—pre-digests lactose
- Hard cheeses have negligible lactose (<1 g per serving)
- A2 milk (only A2 beta-casein) avoids BCM-7 inflammatory pathway while retaining lactose
For lactose-intolerant populations:
- Avoidance: simplest intervention—use lactose-free milk, plant milks
- Lactase supplementation: 6,000-9,000 FCC units with meals (variable efficacy—depends on residual enzyme activity)
- Incremental adaptation: gradual exposure may upregulate colonic β-galactosidase in some individuals (controversial)
- Address calcium intake: non-dairy sources (leafy greens, sardines, fortified foods) or supplementation (calcium citrate 500-1000 mg/day)
- Probiotic adjunct: Lactobacillus acidophilus, Bifidobacterium lactis produce lactase—may reduce symptoms
Connection to A1 beta-casein intolerance:
- Many patients diagnosed with "lactose intolerance" actually have A1 beta-casein intolerance as the primary problem
- BCM-7 (from A1 casein) → Th2 activation → brush border enzyme depletion → secondary lactase deficiency
- Treating only lactose (lactase supplements, lactose-free milk) misses the root cause
- Clinical test: Switch to A2 milk (or goat/sheep milk) while keeping lactose—if symptoms resolve, it's casein, not lactose
¶ Metamodel Integration
Metamodel 1 (Genetics and Epigenetics):
- LCT gene polymorphisms determine phenotype—one of the clearest examples of genetic variation driving clinical outcomes
- Epigenetic regulation of LCT promoter during weaning—a developmental window
Metamodel 3 (Evolutionary Mismatch):
- Dairy consumption in lactose-intolerant populations = profound mismatch
- Industrial dairy processing removes beneficial bacteria (raw vs pasteurized)
- High lactose loads (modern portion sizes) exceed evolutionary exposure
Metamodel 5 (Selfish Systems):
- Selfish Brain: chronic GI symptoms → vagal inflammation → reduced BDNF, cognitive fog
- Selfish Immune System: chronic gut inflammation → systemic cytokine spillover → sickness behaviour
¶ Key Facts
- 65% of global adult population is lactose intolerant—ancestral human phenotype
- Lactase persistence is a derived mutation (5,000-10,000 years old), strongest recent positive selection signal
- -13910 C>T polymorphism (rs4988235): T allele = lactase persistence in Europeans
- Symptom onset: typically 30 minutes to 2 hours post-ingestion (depends on gastric emptying, dose)
- Lactose threshold: most intolerant individuals tolerate <12 g (1 cup milk = 12-15 g, hard cheese <1 g)
- Hydrogen breath test: >20 ppm H₂ rise = positive (false negatives in methanogen producers—test CH₄)
- Fermented dairy better tolerated: bacterial β-galactosidase pre-digests lactose (yogurt, kefir ~3-5 g lactose)
- Secondary lactase deficiency can occur from celiac disease, Crohn's disease, SIBO, rotavirus infection
- Prevalence extremes: 5% in Northern Europeans vs 90-100% in East Asians
- Not an allergy: lactose intolerance is enzymatic deficiency; milk protein allergy is IgE/IgG-mediated immune response
- FODMAP connection: lactose is a fermentable oligosaccharide—overlaps with IBS triggers
- Microbiome shift: chronic malabsorption selects for gas-producing bacteria, reduces diversity
¶ Connections
- Lactase persistence — opposite phenotype; genetic adaptation enabling lifelong lactose digestion via -13910 C>T polymorphism
- lactase — brush border enzyme deficiency causing intolerance; LPH protein on jejunal enterocyte apical membrane
- SGLT1 — sodium-glucose co-transporter cannot transport intact lactose; requires monosaccharides from lactase cleavage
- gut dysbiosis — chronic lactose malabsorption selects for gas-producing bacteria, reduces Firmicutes, increases Proteobacteria
- gut microbiome — colonic bacteria (Bacteroides, E. coli) ferment lactose producing H₂, CH₄, SCFAs
- evolutionary mismatch — dairy consumption in non-persistent populations represents dietary mismatch with ancestral biology
- SCFA — bacterial lactose fermentation produces acetate, propionate, butyrate; beneficial but contribute to symptoms via acidification
- fermentation — colonic bacterial fermentation produces gas and osmotic diarrhea; measured in hydrogen breath test
- diarrhea — osmotic diarrhea from unabsorbed lactose (15 mL water/g lactose) plus secretory component from PGE2 release
- bloating — gas production (H₂, CH₄, CO₂) and mechanical distension activate visceral afferents
- A1 beta-casein — protein intolerance often confused with lactose intolerance; BCM-7 depletes brush border enzymes causing secondary lactase deficiency
- BCM-7 — opioid peptide from A1 casein triggers Th2 activation, brush border damage, secondary lactase loss
- calcium — dairy avoidance requires alternative sources (leafy greens, sardines) or supplementation (500-1000 mg/day calcium citrate)
- inflammation — chronic malabsorption triggers low-grade inflammation via LPS translocation, TLR4 activation, NF-κB pathway
- IBS — lactose intolerance mimics or exacerbates irritable bowel syndrome; overlapping symptom profiles
- FODMAP — lactose is a fermentable disaccharide; key trigger in FODMAP-sensitive individuals
- Low-FODMAP diet — restricts lactose to
g per meal; first-line dietary intervention for IBS and lactose intolerance - SIBO — small intestinal bacterial overgrowth ferments lactose proximally, mimicking lactose intolerance on breath testing
- genetic variation — LCT gene polymorphisms determine phenotype; strongest recent positive selection in human evolution
- Breastmilk — all infants produce lactase for breast milk digestion (7% lactose); downregulation begins age 2-5
- ethnicity — prevalence varies dramatically: 5% Northern Europeans vs 90-100% East Asians
- nutrition — affects dietary strategies; requires calcium planning, evaluation of fermented dairy tolerance
- leaky gut — chronic distension and acidification from lactose malabsorption can increase intestinal permeability
- TLR4 — activated by LPS from bacterial translocation secondary to chronic lactose fermentation
- NF-κB — transcription factor activated by LPS, driving inflammatory cytokine production in chronic intolerance
- IL-6 — pro-inflammatory cytokine elevated with chronic gut inflammation from lactose malabsorption
- Lactobacillus — probiotic species (L. acidophilus, L. rhamnosus) produce β-galactosidase, may reduce symptoms
- Bifidobacterium — B. lactis produces lactase enzyme; probiotic supplementation may improve tolerance
- gene-culture coevolution — lactase persistence arose in dairy-farming populations; culture (dairying) drove genetic selection
- Th2 — activated by BCM-7 in A1 casein intolerance, suppresses Th1, depletes brush border enzymes including lactase
¶ Module References
- Module 1